A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...
IRVINE, Calif.--(BUSINESS WIRE)--CG Oncology, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted both Fast Track Designation and Breakthrough Therapy Designation for ...
An expert told Newsweek: "With cases rising globally, it’s never been more important to understand what’s driving this trend." ...
Hosted on MSN
Scientists discover how top cancer killer spreads so fast and a new treatment that can stop it
A discovery into the cause of one of the deadliest cancers has been uncovered, which could hold the key to new treatments, scientists said. The American Cancer Society estimates that 21,000 women will ...
A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic ...
- In previous Phase 2 clinical trials involving more than 400 patients, ACR-368 produced deep, durable monotherapy responses, including complete responses, in a proportion of patients with solid ...
JSKN003 has shown a 63% objective response rate and 7.7 months median progression-free survival in PROC patients, with higher efficacy in HER2-positive subgroups. The FDA's fast track designation ...
FAST-Forward is a major international clinical trial investigating the best way to deliver radiotherapy for early breast cancer. It compared the standard three-week schedule (40Gy in 15 treatments) ...
The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found. The research findings, published in Nature, have implications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results